Effects of dapagliflozin on body composition and its relation to hemodynamics in heart failure with preserved ejection fraction: the CAMEO-DAPA randomized clinical trial
31 August 2024 (10:00 - 10:10)
Organised by: 
About the speaker
Mayo Clinic, Rochester (United States of America)
5 More presentations in this session
Associate Professor A. Abdin (Homburg, DE)
Associate Professor S. Bu (Uijeongbu, KR)
Professor S. von Haehling (Goettingen, DE)
Access the full session
The Event
ESC Congress 2024
31 August 2024
10:00 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
